LALANI, Aly-Khan A. et al. First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience. Canadian Urological Association Journal, [S. l.], v. 11, n. 3-4, p. 112–7, 2017. DOI: 10.5489/cuaj.4398. Disponível em: https://cuaj.ca/index.php/journal/article/view/4398. Acesso em: 26 may. 2026.